Latest filing published 27 Mar 2026 for SK바이오사이언스.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -12.4%Entry ₩42,300 · Close 08 Oct 2026 ₩37,050
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sk케미칼: trading record in brief
Sk케미칼 has filed trades across 2 companies (mainly through DART (FSS)), most often in SK케미칼 and SK바이오사이언스. Over a trading history stretching from 16 March 2021 to 23 March 2026, the count stands at 8 filings.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
On 27 March 2026 came the latest disclosure, an open-market purchase in SK바이오사이언스. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to Sk케미칼
Open company profiles for insider transactions, fundamentals and analyst consensus when available.